Coverage
-
August 13, 2013
Gilead Sciences Inc. and Roche Palo Alto LLC have abandoned a patent infringement suit trying to block Lupin Ltd. from offering a copycat version of chronic chest pain treatment Ranexa, telling a New Jersey federal judge Friday that they'd resolved their dispute.
1 other articles on this case.
View all »